BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 11498462)

  • 1. Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo.
    Shaw PX; Hörkkö S; Tsimikas S; Chang MK; Palinski W; Silverman GJ; Chen PP; Witztum JL
    Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1333-9. PubMed ID: 11498462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice.
    Tsimikas S; Palinski W; Witztum JL
    Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):95-100. PubMed ID: 11145939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human monoclonal Fab and human plasma antibodies to carbamyl-epitopes cross-react with malondialdehyde-adducts.
    Kummu O; Turunen SP; Prus P; Lehtimäki J; Veneskoski M; Wang C; Hörkkö S
    Immunology; 2014 Mar; 141(3):416-30. PubMed ID: 24168430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins.
    Hörkkö S; Bird DA; Miller E; Itabe H; Leitinger N; Subbanagounder G; Berliner JA; Friedman P; Dennis EA; Curtiss LK; Palinski W; Witztum JL
    J Clin Invest; 1999 Jan; 103(1):117-28. PubMed ID: 9884341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL.
    Ylä-Herttuala S; Palinski W; Butler SW; Picard S; Steinberg D; Witztum JL
    Arterioscler Thromb; 1994 Jan; 14(1):32-40. PubMed ID: 7506053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.
    Palinski W; Hörkkö S; Miller E; Steinbrecher UP; Powell HC; Curtiss LK; Witztum JL
    J Clin Invest; 1996 Aug; 98(3):800-14. PubMed ID: 8698873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes.
    Freigang S; Hörkkö S; Miller E; Witztum JL; Palinski W
    Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1972-82. PubMed ID: 9848892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophages and oxidized low density lipoproteins in the pathogenesis of atherosclerosis.
    Ylä-Herttuala S
    Ann Med; 1991; 23(5):561-7. PubMed ID: 1721825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo visualization and attenuation of oxidized lipid accumulation in hypercholesterolemic zebrafish.
    Fang L; Green SR; Baek JS; Lee SH; Ellett F; Deer E; Lieschke GJ; Witztum JL; Tsimikas S; Miller YI
    J Clin Invest; 2011 Dec; 121(12):4861-9. PubMed ID: 22105168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum.
    Palinski W; Ord VA; Plump AS; Breslow JL; Steinberg D; Witztum JL
    Arterioscler Thromb; 1994 Apr; 14(4):605-16. PubMed ID: 7511933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rethinking oxidized low-density lipoprotein, its role in atherogenesis and the immune responses associated with it.
    Shaw PX
    Arch Immunol Ther Exp (Warsz); 2004; 52(4):225-39. PubMed ID: 15467487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of human monoclonal autoantibody Fab fragments against oxidized LDL.
    Jeon YE; Seo CW; Yu ES; Lee CJ; Park SG; Jang YJ
    Mol Immunol; 2007 Feb; 44(5):827-36. PubMed ID: 16793138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression.
    Tsimikas S; Miyanohara A; Hartvigsen K; Merki E; Shaw PX; Chou MY; Pattison J; Torzewski M; Sollors J; Friedmann T; Lai NC; Hammond HK; Getz GS; Reardon CA; Li AC; Banka CL; Witztum JL
    J Am Coll Cardiol; 2011 Oct; 58(16):1715-27. PubMed ID: 21982317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to oxidized LDL in atherosclerosis development--clinical and animal studies.
    Hulthe J
    Clin Chim Acta; 2004 Oct; 348(1-2):1-8. PubMed ID: 15369729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis.
    Palinski W; Tangirala RK; Miller E; Young SG; Witztum JL
    Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1569-76. PubMed ID: 7583529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis.
    Palinski W; Miller E; Witztum JL
    Proc Natl Acad Sci U S A; 1995 Jan; 92(3):821-5. PubMed ID: 7846059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model IgG monoclonal autoantibody-anti-idiotype pair for dissecting the humoral immune response to oxidized low density lipoprotein.
    Chang SH; Johns M; Boyle JJ; McConnell E; Kirkham PA; Bicknell C; Zahoor-ul-Hassan Dogar M; Edwards RJ; Gale-Grant O; Khamis R; Ramkhelawon KV; Haskard DO
    Hybridoma (Larchmt); 2012 Apr; 31(2):87-98. PubMed ID: 22509912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune complexes containing malondialdehyde (MDA) LDL induce apoptosis in human macrophages.
    Virella G; Wilson K; Elkes J; Hammad SM; Rajab HA; Li Y; Chassereau C; Huang Y; Lopes-Virella M
    Clin Immunol; 2018 Feb; 187():1-9. PubMed ID: 28689783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition.
    Chang MK; Bergmark C; Laurila A; Hörkkö S; Han KH; Friedman P; Dennis EA; Witztum JL
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6353-8. PubMed ID: 10339591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies against oxidized LDL--theory and clinical use.
    Steinerová A; Racek J; Stozický F; Zima T; Fialová L; Lapin A
    Physiol Res; 2001; 50(2):131-41. PubMed ID: 11522041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.